Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Kentucky Prevention Research Center
Etiology of Sarcoidosis a Case Control Study
Methadone Maintenance Quality
Pediatric Cohort of the Csscd
Mechanisms of Chemical Induced Skin Toxicity
Recently added grants:
Central Limitations to Exercise Performance in HFpEF
Targeting skeletal muscle to improve exercise capacity in heart failure with preserved ejection fraction.
The Functional Role of Mediodorsal Thalamic Input onto the Mouse Lateral Orbitofrontal Cortex in Incentive Learning
Autonomic Circulatory Control in Patients with HFpEF
Pulmonary Mechanisms of Dyspnea in HFpEF: Impact of Obesity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67183-3-0-1
Application #
7574883
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ U of L Imperial Col of Sci/Technlgy/Med
$559,538
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gibbs, Simon /
$649,798
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant